文献速递瓣膜外科主动脉外科

系统综述与荟萃分析:马凡综合征患者Bentall与David手术的长期结果

A systemic review and meta-analysis: long-term results of the Bentall versus the David procedure in patients with Marfan syndrome.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

该系统综述与荟萃分析纳入20项回顾性研究共2156例马凡综合征患者,比较主动脉瓣再植入(RAV)与复合瓣膜移植物(CVG)手术的长期结果。住院死亡率有利于RAV(OR 0.23,95%CI 0.09-0.55,P=0.001);中期生存率RAV组96.7% vs CVG组86.4%,长期生存率RAV组93.1% vs CVG组82.6%;长期免于瓣膜相关再干预率RAV组97.6% vs CVG组88.6%。作者认为RAV是主动脉根部手术的首选治疗。

要点

  • 住院死亡率有利于RAV手术(OR 0.23,95%CI 0.09-0.55,P=0.001)。
  • 中期生存率RAV组96.7% vs CVG组86.4%;长期生存率RAV组93.1% vs CVG组82.6%。
  • 长期免于瓣膜相关再干预率RAV组97.6% vs CVG组88.6%。

核心结论

  • 该系统综述强调RAV手术在马凡综合征患者中长期和短期结果方面的优势,为主动脉根部手术的首选治疗。
  • RAV手术降低住院死亡和长期死亡,并防止主动脉瓣再干预。

研究设计与样本

  • 系统综述与荟萃分析,纳入20项回顾性研究,共2156例马凡综合征患者,具有长期随访。
  • 采用随机效应荟萃回归分析研究臂,以对数转换的住院死亡比例为结局指标(可行时)。
  • 结果以比值比(OR)及95%置信区间(CI)和P值呈现;其他结局以中位数、四分位距(IQR)、范围和风险患者数总结。

主要发现

  • 住院死亡率有利于RAV手术,OR 0.23(95%CI 0.09-0.55,P=0.001)。
  • 中期生存率RAV组96.7%(CI 94.2-98.5)vs CVG组86.4%(CI 82.8-89.6)。
  • 长期生存率RAV组93.1%(CI 66.4-100)vs CVG组82.6%(CI 74.9-89.2)。
  • 长期免于瓣膜相关再干预率(中位数百分比)RAV组97.6%(CI 90.3-100%)vs CVG组88.6%(CI 79.1-95.5)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This systemic review of the literature and meta-analysis aimed to evaluate the current state of the evidence for and against reimplantation of the aortic valve (RAV) versus the composite valve graft (CVG) intervention in patients with Marfan syndrome. Random effects meta-regression was performed across the study arms with logit-transformed proportions of in-hospital deaths as an outcome measure when possible. Results are presented as odds ratios with 95% confidence intervals (CIs) and P-values. Other outcomes are summarized with medians, interquartile ranges (IQR) and ranges and the numbers of patients at risk. Twenty retrospective studies that included a combined 2156 patients with long-term follow-up were identified for analysis after a literature search. The in-hospital mortality rate favoured the RAV procedure with an odds ratio of 0.23 [95% CI 0.09-0.55, P = 0.001]. The survival rate at mid-term for the RAV cohort was 96.7% (CI 94.2-98.5) vs. 86.4% (CI 82.8-89.6) for the CVG group and 93.1% (CI 66.4-100) for the RAV group vs. 82.6% (CI 74.9-89.2) for the CVG group for the long term. Freedom from valve-related reintervention (median percentages) for the long term was 97.6% (CI 90.3-100%) for the RAV procedure and 88.6% (CI 79.1-95.5) for a CVG. This systematic review of the literature stresses the advantages of the RAV procedure in patients with Marfan syndrome in regard to long- and short-term results as the treatment of choice in aortic root surgery. The RAV procedure reduces in-hospital as well as long-term deaths and protects against aortic valve reintervention.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Burgstaller JM, Held U, Mosbahi S, et al. A systemic review and meta-analysis: long-term results of the Bentall versus the David procedure in patients with Marfan syndrome. Eur J Cardiothorac Surg. 2018. PMID: 29893811. doi:10.1093/ejcts/ezy158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。